by Samy Sriram
Share

Payday

Tariff refunds, earnings season and a volatile market. Payoff hinges on turning short-term gains into lasting momentum.

If you inverted Nike’s ($NKE) swoosh logo, you’d get something far less iconic with an uncanny resemblance to the stock’s 5-year price chart. A billion-dollar payday might help it along.

On Monday, the portal for U.S. retailers to claim tariff refunds went live, after the U.S. Supreme Court ruled the levies illegal. Nike could receive US$1B, according to Citigroup – modest next to Walmart’s ($WMT) estimated US$10.2B haul, with total payouts expected to top US$160B.

That’s real cash. Refunds could be used to fund buybacks, pay down debt, or flow straight into earnings down the line. But for now, investor focus is on whether the ongoing earnings season will pay off. This week, around 20% of the S&P 500 reports, including Intel ($INTC) and Tesla ($TSLA).

For Elon Musk, the stakes go well beyond a single quarter. His compensation is tied to some of the most ambitious targets in corporate history: one million robotaxis, 20 million vehicles and a US$8.5T Tesla valuation. Hit them, and his payday could reach US$1T.

At Apple ($AAPL), pay has already been front and centre. Tim Cook took home US$74.6M last year, mostly in stock. Cook took Apple’s market cap from US$350B to US$4T in his 15-year tenure. Now, with hardware chief John Ternus set to take over as CEO, the focus shifts to whether Apple can convert its US$400B revenue machine into an AI leader.

The AI world is well-acquainted with outsized paychecks. And of course, the circular funding playbook. Anthropic struck a massive deal with Amazon ($AMZN) this week, where the latter has agreed to invest up to US$25B in the Claude creator. In turn, Anthropic has agreed to spend over US$100B on Amazon’s chips over the next decade. 

Amazon’s push into healthcare is creating its own ripple effects. The company is expanding into a GLP-1 program, offering popular weight-loss drugs through Amazon Pharmacy for as low as US$25. That move knocked shares of telehealth firm Hims & Hers ($HIMS) down 4% in Tuesday’s session – a reminder that one company’s windfall can be another’s setback.

For investors, the next payday might take a little longer to arrive. After the S&P 500 hit fresh records last week, volatility made a quick return with geopolitical uncertainty. 

Timing the market is a great skill to have. But in this environment, waiting it out might have the better payoff. 

This is not financial advice nor a recommendation to invest in the securities listed. The information presented is for general information purposes only and intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. The author of this article and other employees of Stakeshop Pty Ltd may hold positions or have financial interests in the company (or companies) discussed above. As always, do your own research and consider seeking financial, legal and taxation advice before investing.


Portrait photo of Samy Sriram, Markets Analyst at Stake.

Samy Sriram

Markets Analyst

Samy is a markets analyst at Stake, with seven years of experience in the world of investing, working across roles in private banking, venture capital and financial media. She has a Master’s degree in Finance and Data Analytics from The University of Sydney Business School.


Related


Want more?

You know what to do

Insights, trends and company deep dives delivered straight to your inbox.


Stake logo
Over 12,000 5-star reviews
App Store logoGoogle Play logo

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.

Stakeshop Pty Ltd is registered as an overseas company in New Zealand (NZBN: 9429047452152), and is registered as a Financial Service Provider under the Financial Service Providers (Registration and Dispute Resolution) Act 2008 (No. FSP774414). We hold a full licence issued by the Financial Markets Authority to provide a financial advice service under the Financial Markets Conduct Act 2013. However, the content on this website has not been prepared to take into account any of your individual objectives, financial situation or needs. To the extent you require further information about the relevant New Zealand legislation that may apply, or require specific advice, please contact your legal and/or financial adviser (as appropriate). The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Terms & Conditions, Privacy Policy, Financial Advice Disclosure and Disclaimers before deciding to use or invest on Stake. By using the Stake website or service in any way, you agree to our Privacy Policy and Terms & Conditions All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake is a registered trademark under class 36 (New Zealand).

Copyright © 2026 Stake. All rights reserved.